PAVmed End Period Cash Flow from 2010 to 2024

PAVM Stock  USD 0.85  0.0001  0.01%   
PAVmed End Period Cash Flow yearly trend continues to be very stable with very little volatility. End Period Cash Flow is likely to drop to about 19 M. During the period from 2010 to 2024, PAVmed End Period Cash Flow quarterly data regression pattern had sample variance of 434.8 T and median of  1,678,154. View All Fundamentals
 
End Period Cash Flow  
First Reported
2014-12-31
Previous Quarter
25.5 M
Current Value
765 K
Quarterly Volatility
22.6 M
 
Yuan Drop
 
Covid
Check PAVmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 559.5 K or Selling General Administrative of 32.5 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Valuation or Volatility modules.
  
Check out the analysis of PAVmed Correlation against competitors.

Latest PAVmed's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of PAVmed Inc over the last few years. It is PAVmed's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

PAVmed End Period Cash Flow Regression Statistics

Arithmetic Mean13,242,439
Geometric Mean4,618,898
Coefficient Of Variation157.46
Mean Deviation14,227,240
Median1,678,154
Standard Deviation20,851,179
Sample Variance434.8T
Range76.7M
R-Value0.60
Mean Square Error298T
R-Squared0.36
Significance0.02
Slope2,810,989
Total Sum of Squares6086.8T

PAVmed End Period Cash Flow History

202419 M
202319.6 M
202239.7 M
202177.3 M
202017.3 M
20196.2 M
20188.2 M

About PAVmed Financial Statements

PAVmed investors utilize fundamental indicators, such as End Period Cash Flow, to predict how PAVmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow19.6 M19 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out the analysis of PAVmed Correlation against competitors.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Revenue Per Share
0.459
Quarterly Revenue Growth
4.898
Return On Assets
(0.80)
Return On Equity
(13.58)
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.